Genetic risk factors for type 1 diabetes

@article{Pociot2016GeneticRF,
  title={Genetic risk factors for type 1 diabetes},
  author={F. Pociot and {\AA}. Lernmark},
  journal={The Lancet},
  year={2016},
  volume={387},
  pages={2331-2339}
}
Type 1 diabetes is diagnosed at the end of a prodrome of β-cell autoimmunity. The disease is most likely triggered at an early age by autoantibodies primarily directed against insulin or glutamic acid decarboxylase, or both, but rarely against islet antigen-2. After the initial appearance of one of these autoantibody biomarkers, a second, third, or fourth autoantibody against either islet antigen-2 or the ZnT8 transporter might also appear. The larger the number of β-cell autoantibody types… Expand
Early prediction of autoimmune (type 1) diabetes
TLDR
As the understanding of the aetiology and pathogenesis of type 1 diabetes advances, the improved capability for early prediction should guide new strategies for the prevention of type 2 diabetes. Expand
Type 1 diabetes mellitus
TLDR
A cure is not available, and patients depend on lifelong insulin injections; novel approaches to insulin treatment, such as insulin pumps, continuous glucose monitoring and hybrid closed-loop systems, are in development. Expand
The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children
TLDR
The understanding of the aetiology and pathogenesis of T1D in childhood is expanded by detailed description and comparison of factors affecting the progression from the islet autoimmunity to T1d in children. Expand
Prediction and Prevention of Type 1 Diabetes
TLDR
This review focuses on the major current knowledge on prediction and prevention of T1D in children and the availability of novel humoral and metabolic biomarkers that are able to characterize subjects at high risk of progression. Expand
Novel genetic risk factors influence progression of islet autoimmunity to type 1 diabetes
TLDR
Evidence is provided that genetic pathways involved in progression from islet autoimmunity differ from those pathways identified once disease has been established, and the need for further investigation of genetic risk factors that modulate initiation and progression of subclinical disease to inform efforts in development of novel strategies for prediction and intervention of type 1 diabetes. Expand
The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report
TLDR
The TEDDY data suggest that non-HLA gene polymorphisms may play a different role in the initiation of autoimmunity than they do in progression to type 1 diabetes (T1D) once autoIMmunity has appeared. Expand
Risk of beta-cell autoimmunity presence for progression to type 1 diabetes: A systematic review and meta-analysis.
TLDR
This study established the association between the seroconversion of islet autoantibodies and T1 DM progression in nondiabetic people with or without definite genetic susceptibility, providing further evidence for an extensive application in routine clinical practice to identify individuals at risk of T1DM. Expand
Early life origin of type 1 diabetes
TLDR
Putative endogenous factors that may contribute to the development of T1D during fetal and early postnatal life are discussed, some of them most likely already during pregnancy. Expand
Prediction and prevention of type 1 diabetes in children
  • F. Chiarelli, C. Giannini, Marina Primavera
  • Medicine
  • Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
  • 2019
TLDR
The most recent progresses in this field pave the way for future studies, with the aim of preventing T1D in children, according to which the detection of two or more autoantibodies in the blood, might describe those children at increased risk of developing T 1D during the following years. Expand
Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies
TLDR
The results suggest that HLA-DQ cell surface expression was related to HLA and autoimmunity burden. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 64 REFERENCES
Patterns of β-Cell Autoantibody Appearance and Genetic Associations During the First Years of Life
TLDR
The primary autoantigen in the development of β-cell autoimmunity and T1D seems to strongly correlate with age and genetic factors, indicating heterogeneity in the initiation of the disease process. Expand
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study
TLDR
Islet autoantibodies can occur very early in life and the order of appearance was related to HLA-DR-DQ genotype, but GADA only increased until the second year and remained relatively constant. Expand
Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
TLDR
Observations suggest that HLA genes have a strong impact on the appearance of diabetes-associated autoantibodies both in first-degree relatives of affected children and in the general population. Expand
Environmental triggers of type 1 diabetes.
  • M. Knip, O. Simell
  • Biology, Medicine
  • Cold Spring Harbor perspectives in medicine
  • 2012
TLDR
Recent data suggests that the initiation of autoimmunity is preceded by inflammation reflected by a proinflammatory metabolic serum profile, and given that the intestinal microbiome appears to differ between individuals who progress to clinical T1D and nonprogressors, one may speculate that changes in the gut microflora might contribute to the inflammatory process. Expand
Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes
TLDR
SNPs in five susceptibility loci are identified as significantly associated with more than one autoantibody at a false discovery rate less than 5%. Expand
Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes.
TLDR
It is concluded that age and genetic factors such as HLA-DQ and INS VNTR need to be combined with islet autoantibody markers when evaluating the risk for type 1 diabetes development. Expand
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
TLDR
The majority of children at risk of type 1 diabetes who had multiple islet autoantibody seroconversion progressed to diabetes over the next 15 years, and future prevention studies should focus on this high-risk population. Expand
Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.
TLDR
Presentation of IAAs is a consistent feature of this autoimmunity, and IAA detection can identify children at risk, and IAAs were detected most frequently. Expand
Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
TLDR
Although genes in the HLA region remain the most important genetic risk factors for type 1 diabetes, other non-HLA genetic factors contribute to IA, a first step in the pathogenesis of T1D, and the progression of the disease. Expand
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
TLDR
The evidence is discussed that autoimmune type 1 diabetes has a broad clinical phenotype with diverse therapeutic options, while the term non-autoimmune type 2 diabetes obscures the optimal management strategy because it encompasses substantial heterogeneity. Expand
...
1
2
3
4
5
...